In clinical pancreatic adenocarcinoma (PAAD in Figure 1D) samples in The Cancer Genome Atlas database, DLEU2L was more highly expressed in adjacent normal tissues than in tumor tissues (the relative expression levels of DLEU2L and miR-210-3p in various tumor and normal tissues, detected in a pre-study, are shown in Supplementary Figure 1). This evidence concerns the gene DLEU2L and pancreatic adenocarcinoma.